Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 3
1993 3
1994 1
1995 6
1996 2
1997 6
1998 6
1999 5
2000 7
2001 5
2002 10
2003 6
2004 1
2005 6
2006 4
2007 4
2008 2
2009 6
2010 5
2011 2
2012 3
2013 2
2014 2
2015 3
2016 3
2018 1
2019 3
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ecabet
Your search for evabet retrieved no results
Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis.
Wang Y, Wang B, Lv ZF, Yang Y, Wang F, Wang H, Chen S, Xie Y, Zhou X. Wang Y, et al. Helicobacter. 2014 Oct;19(5):372-81. doi: 10.1111/hel.12136. Epub 2014 May 14. Helicobacter. 2014. PMID: 24826809 Review.
CONCLUSION: Supplementation with ecabet sodium during H. pylori eradication therapy improves the eradication rate. The use of ecabet sodium does not increase the side effects based on our meta-analysis....
CONCLUSION: Supplementation with ecabet sodium during H. pylori eradication therapy improves the eradication rate. The use of ecab …
Ecabet sodium, a locally acting antiulcer drug, inhibits urease activity of Helicobacter pylori.
Ito Y, Shibata K, Hongo A, Kinoshita M. Ito Y, et al. Eur J Pharmacol. 1998 Mar 19;345(2):193-8. doi: 10.1016/s0014-2999(97)01622-1. Eur J Pharmacol. 1998. PMID: 9600637
In order to clarify the mechanism of the anti-Helicobacter pylori action of ecabet sodium (ecabet), a locally acting antiulcer drug, we evaluated the effects of ecabet on H. pylori urease activity in vitro. ...These results suggest that irreversible inhibitio …
In order to clarify the mechanism of the anti-Helicobacter pylori action of ecabet sodium (ecabet), a locally acting antiulcer …
Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells.
Kusumoto K, Kawahara T, Kuwano Y, Teshima-Kondo S, Morita K, Kishi K, Rokutan K. Kusumoto K, et al. Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G300-7. doi: 10.1152/ajpgi.00274.2004. Epub 2004 Sep 30. Am J Physiol Gastrointest Liver Physiol. 2005. PMID: 15458921 Free article.
Pretreatment with 10 mg/ml of a nonabsorbable antigastric ulcer drug, ecabet sodium (ecabet), completely blocked these two mRNA expressions and the upregulation of O2- production. ...In contrast, ecabet had no effect on ethanol- or etoposide-initiated apoptos …
Pretreatment with 10 mg/ml of a nonabsorbable antigastric ulcer drug, ecabet sodium (ecabet), completely blocked these two mRN …
Ecabet sodium inhibits the ability of Helicobacter pylori to induce neutrophil production of reactive oxygen species and interleukin-8.
Shimoyama T, Fukuda S, Liu Q, Nakaji S, Munakata A, Sugawara K. Shimoyama T, et al. J Gastroenterol. 2001 Mar;36(3):153-7. doi: 10.1007/s005350170122. J Gastroenterol. 2001. PMID: 11291877
H. pylori were added to 1 x 10(5) neutrophils and incubated for 30 min in the presence of ecabet. Bacterial suspensions which had been incubated with ecabet for 30 min were also used to stimulate neutrophils. ...The mean fluorescence intensity was found to be attenu …
H. pylori were added to 1 x 10(5) neutrophils and incubated for 30 min in the presence of ecabet. Bacterial suspensions which had bee …
Ecabet sodium alleviates neomycin-induced hair cell damage.
Rah YC, Choi J, Yoo MH, Yum G, Park S, Oh KH, Lee SH, Kwon SY, Cho SH, Kim S, Park HC. Rah YC, et al. Free Radic Biol Med. 2015 Dec;89:1176-83. doi: 10.1016/j.freeradbiomed.2015.11.007. Epub 2015 Nov 10. Free Radic Biol Med. 2015. PMID: 26561773
Ecabet sodium (ES) is currently applied to some clinical gastrointestinal disease primarily by the inhibition of the ROS production. ...
Ecabet sodium (ES) is currently applied to some clinical gastrointestinal disease primarily by the inhibition of the ROS production. …
Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
Shimoyama T, Fukuda Y, Fukuda S, Munakata A, Yoshida Y, Shimoyama T. Shimoyama T, et al. J Gastroenterol. 1996 Nov;31 Suppl 9:59-62. J Gastroenterol. 1996. PMID: 8959522 Clinical Trial.
Ecabet sodium (ecabet), a new agent that has protective effects on the gastric mucosa has anti-Helicobacter pylori effects, binding with urease to inhibit H. pylori activity, and causing the bacterial to become non-viable. Ecabet monotherapy eradicates H. pyl …
Ecabet sodium (ecabet), a new agent that has protective effects on the gastric mucosa has anti-Helicobacter pylori effects, bi …
[Ecabet sodium].
Takahashi S, Tanaka A. Takahashi S, et al. Nihon Rinsho. 2002 Feb;60 Suppl 2:711-6. Nihon Rinsho. 2002. PMID: 11979876 Review. Japanese. No abstract available.
Ecabet sodium raises plasma levels of calcitonin generelated peptide and substance P in healthy humans.
Katagiri F, Inoue S, Sato Y, Itoh H, Takeyama M. Katagiri F, et al. J Pharm Pharmacol. 2005 Jun;57(6):799-805. doi: 10.1211/0022357056271. J Pharm Pharmacol. 2005. PMID: 15969937
Ecabet sodium (ecabet), a cytoprotective drug, produces an increase in mucosal blood flow. ...Ecabet significantly decreased plasma gastrin-IS levels compared with placebo. ...
Ecabet sodium (ecabet), a cytoprotective drug, produces an increase in mucosal blood flow. ...Ecabet significantly decr …
Ecabet sodium, a novel locally-acting anti-ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin-induced disruption in the rat.
Kinoshita M, Endo M, Yasoshima A, Saito N, Yamasaki K, Chishima S, Narita H. Kinoshita M, et al. Aliment Pharmacol Ther. 1999 May;13(5):687-94. doi: 10.1046/j.1365-2036.1999.00502.x. Aliment Pharmacol Ther. 1999. PMID: 10233194 Free article.
AIM: To assess the effect of ecabet on pepsin-induced degradation of the structure of the mucus gel layer. ...CONCLUSION: Ecabet protects the polymeric structure of mucus glycoproteins from proteolytic degradation by pepsin, and thus maintains integrity of the gastr …
AIM: To assess the effect of ecabet on pepsin-induced degradation of the structure of the mucus gel layer. ...CONCLUSION: Ecabet …
109 results